Your browser doesn't support javascript.
loading
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma.
Baumeister, Susanne H; Murad, Joana; Werner, Lillian; Daley, Heather; Trebeden-Negre, Helene; Gicobi, Joanina K; Schmucker, Adam; Reder, Jake; Sentman, Charles L; Gilham, David E; Lehmann, Frédéric F; Galinsky, Ilene; DiPietro, Heidi; Cummings, Kristen; Munshi, Nikhil C; Stone, Richard M; Neuberg, Donna S; Soiffer, Robert; Dranoff, Glenn; Ritz, Jerome; Nikiforow, Sarah.
Affiliation
  • Baumeister SH; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Murad J; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Werner L; Division of Pediatric Hematology-Oncology Boston Children's Hospital, Boston, Massachusetts.
  • Daley H; Harvard Medical School, Boston, Massachusetts.
  • Trebeden-Negre H; Celdara Medical, LLC, Lebanon, New Hampshire.
  • Gicobi JK; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Schmucker A; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Reder J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sentman CL; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gilham DE; Celdara Medical, LLC, Lebanon, New Hampshire.
  • Lehmann FF; Celdara Medical, LLC, Lebanon, New Hampshire.
  • Galinsky I; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
  • DiPietro H; Celyad, SA, Mont-Saint-Guibert, Belgium.
  • Cummings K; Celyad, SA, Mont-Saint-Guibert, Belgium.
  • Munshi NC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Stone RM; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Neuberg DS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Soiffer R; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Dranoff G; Harvard Medical School, Boston, Massachusetts.
  • Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nikiforow S; Harvard Medical School, Boston, Massachusetts.
Cancer Immunol Res ; 7(1): 100-112, 2019 01.
Article in En | MEDLINE | ID: mdl-30396908
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Immunotherapy, Adoptive / Multiple Myeloma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Immunol Res Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Immunotherapy, Adoptive / Multiple Myeloma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Immunol Res Year: 2019 Type: Article